MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    Climb up! Head up! Effectiveness and feasibility of sport climbing in Parkinson’s disease

    A. Langer, H. Zach, S. Hasenauer, A. Flotz, L. Gassner, R. Pokan, P. Dabnichki, L. Wizany, D. Roth, S. Zimmel, M. Treven, M. Schmoeger, U. Willinger, W. Maetzler (Wien, Austria)

    Objective: The current study examines the effectiveness and feasibility of sport climbing in PD patients in a single-centre, randomised controlled, semi-blind trial. Background: Physical activity…
  • MDS Virtual Congress 2021

    Feasibility of dance therapy through synchrony videoconference in Parkinson’s disease and elderly people.

    C. Pinto, C. Figueiredo, V. Mabilia, I. Cortez, F. Pereira, T. Rosa, I. Bevilacqua, E. Jeffrey, A. Pagnussat (Porto Alegre, Brazil)

    Objective: To investigate the safety and effectiveness of online dance classes (in live) in a group of people with and without Parkinson's Disease. Background: Dance…
  • MDS Virtual Congress 2021

    CLE-600: Treating nocturnal and early morning OFF symptomology in Parkinson’s disease with the OLAR® platform

    E. Berkovich (Petch-Tikva, Israel)

    Objective: Development of a treatment for nocturnal and early morning OFF symptomology in Parkinson’s disease. Background: Levodopa Parkinson’s disease (PD) treatment is limited by its…
  • MDS Virtual Congress 2021

    Global access to Parkinson’s disease treatment

    JLY. Cheong, ZHK. Goh, C. Marras, C. Tanner, M. Kasten, A. Korczyn, L. Chahine, R. Lo, A. Noyce (London, United Kingdom)

    Objective: To examine the availability of PD treatment by country, and analyse differences by national income as defined by the World Bank (high income countries…
  • MDS Virtual Congress 2021

    Opicapone in Parkinson’s disease patients with early/simple motor fluctuations: real-world Spanish data

    M. Mata Alvarez-Santullano, C. Borrue Fernández, CM. Labandeira Guerra, T. Muñoz Ruiz, J. Abril Jamarillo, V. Gómez Mayordomo, PE. Bermejo Velasco (San Sebastián Reyes, Spain)

    Objective: To evaluate the efficacy and tolerability of opicapone in patients in Parkinson’s disease (PD) patients with early/simple motor fluctuations (E/S-MF) in the Spanish clinical…
  • MDS Virtual Congress 2021

    Opicapone in Parkinson’s Disease German Patients with Motor Fluctuations: Findings from the OPTIPARK Study

    H. Reichmann, A. Lees, D. Magalhães, J. Rocha, P. Soares-da-Silva (Dresden, Germany)

    Objective: To evaluate opicapone (OPC) when used in everyday clinical practice conditions to treat Parkinson’s disease (PD) patients with motor fluctuations. Background: OPC proved to…
  • MDS Virtual Congress 2021

    Electroconvulsive therapy for refractory psychiatric symptoms in GBA-related Parkinson disease patient

    JY. Yun, EH. Lee (Seoul, Republic of Korea)

    Objective: This case report aims to highlight the ECT as a promising option on refractory neuropsychiatric manifestations of PD. Background: In GBA-related PD, non-motor symptoms…
  • MDS Virtual Congress 2021

    FINANCIAL COST OF PARKINSON’S DISEASE IN BRAZIL IN THE LAST 10 YEARS

    R. Oliveira, S. Moura, L. Cruz, N. Cruz (Salvador, Brazil)

    Objective: Analyzing the financial cost of Parkinson's Disease in Brazil in the last 10 years Background: The Parkinson's disease is a neurodegenerative disease that when…
  • MDS Virtual Congress 2021

    Differentiating Gait Impairments in Early Parkinson’s Disease and Early Dementia with Lewy Bodies

    K. Mathias, A. Pinto, E. Matar, J. Phillips, S. Lewis, K. Ehgoetz Martens (Waterloo, Canada)

    Objective: To characterize and differentiate gait deficits early on in individuals with DLB and PD. Background: Dementia with Lewy bodies (DLB) and Parkinson’s disease (PD)…
  • MDS Virtual Congress 2021

    Cognitive reserve in non-demented patients with Parkinson’s disease might protect against amyloid burden effect on cognition

    B. Fernández-Rodríguez, R. Rodríguez-Rojas, P. Guida, C. Trompeta, D. Mata-Marín, I. Obeso-Martín, L. Vela, L. García-Cañamaque, JA. Obeso, C. Gasca-Salas (Móstoles, Spain)

    Objective: To evaluate the effect of cognitive reserve (CR) in patients with Parkinson’s disease (PD) without dementia. Background: CR concept is a principal factor explaining…
  • « Previous Page
  • 1
  • …
  • 298
  • 299
  • 300
  • 301
  • 302
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley